Clinical Trial Update: SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing SOX (S-1 plus oxaliplatin) versus XELOX (capecitabine plus oxaliplatin) in patients with colorectal cancer metastasized to the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Xeloda (capecitabine)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Colorectal Neoplasm | Phase 2 | Status: UNKNOWN